These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24519468)

  • 1. Novel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluation.
    Alai M; Lin WJ
    AAPS J; 2014 May; 16(3):361-72. PubMed ID: 24519468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluations.
    Alai M; Lin WJ
    Int J Nanomedicine; 2015; 10():4029-41. PubMed ID: 26124659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel once daily microparticulate dosage form comprising lansoprazole to prevent nocturnal acid breakthrough in the case of gastro-esophageal reflux disease: preparation, pharmacokinetic and pharmacodynamic evaluation.
    Alai M; Lin WJ
    J Microencapsul; 2013; 30(6):519-29. PubMed ID: 23294453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lansoprazole on the expression of VEGF and cellular proliferation in a rat model of acetic acid-induced gastric ulcer.
    Kobayashi S; Nakajima N; Ito Y; Moriyama M
    J Gastroenterol; 2010 Aug; 45(8):846-58. PubMed ID: 20333532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nanoparticulate system for sustained delivery of acid-labile lansoprazole.
    Alai MS; Lin WJ
    Colloids Surf B Biointerfaces; 2013 Nov; 111():453-9. PubMed ID: 23867305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
    Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
    J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lansoprazole on gastric ulcer healing and mucin content.
    Komuro Y; Ishii K; Miyake Y; Tanabe S; Oida M; Saigenji K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S47-51. PubMed ID: 7594339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic evaluation of low-dose aspirin-induced gastric and duodenal ulcers during prophylaxis with lansoprazole.
    Sakaki N; Ashida K; Mizokami Y; Chiba T; Matsui S; Kanto T; Uemura N; Hiramatsu N; Sugano K
    Hepatogastroenterology; 2013 Jun; 60(124):762-7. PubMed ID: 23478070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment.
    Kerdsakundee N; Mahattanadul S; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2015 Aug; 94():513-20. PubMed ID: 26143367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freeze dried chitosan/ poly-(glutamic acid) microparticles for intestinal delivery of lansoprazole.
    Singh MN; Yadav HK; Ram M; Shivakumar HG
    Curr Drug Deliv; 2012 Jan; 9(1):95-104. PubMed ID: 21864257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM; Faulds D
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling biopharmaceutical deciding properties of absorption of lansoprazole enteric-coated tablets using gastrointestinal simulation technology.
    Wu C; Sun L; Sun J; Yang Y; Ren C; Ai X; Lian H; He Z
    Int J Pharm; 2013 Sep; 453(2):300-6. PubMed ID: 23806811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB; Faulds D; McTavish D
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat.
    Kuwayama H; Matsuo Y; Eastwood GL
    Am J Med; 1991 Aug; 91(2A):15S-19S. PubMed ID: 1882902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study on the pathophysiology and treatment of PPI-resistant ulcers.
    Ashida K; Sakaguchi M; Tanaka M; Takiuchi H; Egashira Y; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S67-71. PubMed ID: 7594345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructured lipid carriers for transdermal delivery of acid labile lansoprazole.
    Lin WJ; Duh YS
    Eur J Pharm Biopharm; 2016 Nov; 108():297-303. PubMed ID: 27449633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S
    Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of 4- and 8-week lansoprazole treatment for ESD-induced gastric ulcers: a randomized, prospective, controlled study.
    Park JH; Baek EK; Choi CH; Lee KH; Kim BJ; Kim JW; Kim JG; Chang SK
    Surg Endosc; 2014 Jan; 28(1):235-41. PubMed ID: 23996340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
    Aoyama N; Kinoshita Y; Misaki F; Himeno S; Kasuga M; Chiba T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S86-9. PubMed ID: 7594351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.